about
Adaptive and maladaptive expression of the mRNA regulatory protein HuRRegulation of Metastasis by microRNAs in Ovarian CancerOvarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolismCisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian TumorsMicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1Binding sites of miR-1273 family on the mRNA of target genes.The role of microRNAs in ovarian cancerTumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencingMicroRNA-21 regulates hTERT via PTEN in hypertrophic scar fibroblasts.Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1The role and expression of miR-100 and miR-203 profile as prognostic markers in epithelial ovarian cancer.miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.Tumour-suppressor microRNAs regulate ovarian cancer cell physical properties and invasive behaviour.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.Ovarian cancer: diagnostic, biological and prognostic aspects.microRNA and Ovarian Cancer.Recently identified drug resistance biomarkers in ovarian cancer.MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance.miRNAs and ovarian cancer: An overview.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.Expression of miR-146a in patients with ovarian cancer and its clinical significance.Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition.miR-762 can negatively regulate menin in ovarian cancer.Simultaneous Detection of Protein and mRNA in Jurkat and KG-1a Cells by Mass Cytometry.Clinical significance of miRNA-21, -103, -129, -150 in serous ovarian cancer.Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma.
P2860
Q26865703-08511F0C-57D0-4B2C-9986-A4AA2FCEBBD1Q26997006-80792E2D-1CED-41F1-A30C-8BA46BFD3940Q28538384-008B9470-982B-4B7E-BA76-7987AACE4E91Q28550863-1C509715-7891-4902-9E1D-D9364984CA15Q30244282-B6BF27BB-2A5F-41F7-84D8-D8905A68CC33Q33999853-F277756B-99D2-41D1-B10C-14BBB8E37E11Q34162122-1D8F4B13-2190-4467-AB9D-A44892D08F34Q34253436-50037E11-70ED-4DB7-87E5-700642E8C823Q35136473-AB585BF1-1E91-4E47-BF50-3F4546956352Q35166623-54BCF1BA-71DC-44D6-A782-454371A95A0FQ36180735-7ADA2E98-2022-42EF-ADF7-DF9F3C9DF003Q36962391-AB9D856E-FCD5-4268-BE22-958DB11EE26DQ36964202-FF455112-43BD-4CFC-ADAE-D58488B31F73Q37295543-2D173D8C-0194-4A6C-9517-6F0BCB7F5F5CQ37373129-9E93983A-C81F-4601-8A56-B74ED9368665Q37427776-FD30E1D6-702E-49B6-913C-AD2F37297AC4Q37464162-4865F0CA-1F6D-481A-B5D0-DA138E6AF069Q38258014-7A48080B-8A62-4384-B8F1-FAC5CB2CDAB4Q38261795-2D7121F5-E4B3-48AA-B129-D3717FAA997FQ38667018-3469042D-380E-4618-A2E4-1C71465138AAQ38741073-10BC7197-7609-4982-AC16-9E10D0E1839EQ39037653-1D907163-422D-4057-BEFB-84F5B9C93B1BQ39432311-38DBEBBF-622A-4869-960B-88BDC2E12EA6Q41006936-ADA6F045-D013-4599-9FC8-A8058A45CB9EQ41552639-84575261-589F-4413-BD1E-3C25F0AE5B02Q41618429-18CE949C-E9D3-4413-B494-ED11F0732AD8Q42036173-02A4D5B4-7251-487C-9A13-E2AA52E9E8BCQ42155150-67D5DF97-7ACB-4896-A895-B53012FA5363Q46721245-AB71DB7A-A282-4981-B198-443CB669DFC4Q48239077-45FE5F50-DD76-4FD0-9BE6-DDF6269215AAQ54962236-01694D3A-204C-49A0-B0BD-A7521CABC466
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Identification of ovarian cancer metastatic miRNAs
@ast
Identification of ovarian cancer metastatic miRNAs
@en
Identification of ovarian cancer metastatic miRNAs
@nl
type
label
Identification of ovarian cancer metastatic miRNAs
@ast
Identification of ovarian cancer metastatic miRNAs
@en
Identification of ovarian cancer metastatic miRNAs
@nl
prefLabel
Identification of ovarian cancer metastatic miRNAs
@ast
Identification of ovarian cancer metastatic miRNAs
@en
Identification of ovarian cancer metastatic miRNAs
@nl
P2093
P2860
P3181
P1433
P1476
Identification of ovarian cancer metastatic miRNAs
@en
P2093
Alexander S Brodsky
Andrew Fischer
Colin Collins
Daniel H Miller
Elijah Douglass
Hsin-Ta Wu
Lauren Comisar
Margaret Steinhoff
Shannon MacLaughlan
Souriya Vang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0058226
P407
P577
2013-03-12T00:00:00Z